SCUELJapan healthcare data

Home › Therapeutic areas › Antihistamines

Japan market screening · Therapeutic class

Antihistamines in Japan

抗ヒスタミン剤 · Japan Standard Commodity Classification

10 molecules in this class are marketed in Japan across 46 products. 6 of those products are not shipping normally today — 13.0% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.

10Molecules
46Marketed products
6Products constrained

Molecules in this class

Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.

MoleculeProducts CompaniesConstrained Supply mix
Mequitazineメキタジン106—
Clemastine Fumarateクレマスチンフマル酸塩841
d-Chlorpheniramine Maleated-クロルフェニラミンマレイン酸塩851
Chlorpheniramine Maleateクロルフェニラミンマレイン酸塩661
Promethazine Hydrochlorideプロメタジン塩酸塩521
Cyproheptadine Hydrochloride Hydrateシプロヘプタジン塩酸塩水和物311
Diphenhydramine Hydrochlorideジフェンヒドラミン塩酸塩32—
Alimemazine Tartrateアリメマジン酒石酸塩11—
Diphenhydramine Hydrochloride / Calcium Bromideジフェンヒドラミン塩酸塩・臭化カルシウム111
Promethazine Methylenedisalicylateプロメタジンメチレンジサリチル酸塩11—
Normal supply Limited supply Supply suspended

How to read this

Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.

Screening this area in Japan?

Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.

Send an enquiry

Our Database Division replies in English within three business days (Japan time).